EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, LifeMD's enterprise value is $229.2 Mil.
LifeMD's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $-10.1 Mil. Therefore, LifeMD's EV-to-EBITDA for today is -22.64.
The historical rank and industry rank for LifeMD's EV-to-EBITDA or its related term are showing as below:
LFMD'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -96.86 Med: -7.81 Max: -0.78
Current: -22.64
During the past 13 years, the highest EV-to-EBITDA of LifeMD was -0.78. The lowest was -96.86. And the median was -7.81.
LFMD's EV-to-EBITDA is ranked worse than 100% of 481
companies
in the Healthcare Providers & Services industry
Industry Median: 12.34
vs LFMD: -22.64
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-12-13), LifeMD's stock price is $5.69.
LifeMD's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.640. Therefore, LifeMD's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
LifeMD EV-to-EBITDA Historical Data
The historical data trend for LifeMD's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, LifeMD's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeMD's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where LifeMD's EV-to-EBITDA falls into.
LifeMD's current Enterprise Value is $229.2 Mil.
LifeMD's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeMD (NAS:LFMD) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LifeMD's share price for today is $5.69.
LifeMD's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of LifeMD's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LFMD has been successfully added to your 